SSSS Study:Cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease in Canada. -国际循环网

当前位置：循环首页>正文

SSSS Study:Cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease in Canada.

作者:国际循环网日期:2004/10/12 0:00:00

OBJECTIVE: To determine the cost-effectiveness of simvastatin in the secondary prevention of coronary artery disease (CAD) in Canada. DESIGN: Cost-effectiveness model based on results from the Scandinavian Simvastatin Survival Study (45 study) and cost and resource utilization data from Canadian sources to simulate the economic impact of long-term simvastatin treatment (15 years). PATIENTS: Subjects with mean age of 59.4 years at recruitment into 4S study.

6108 respectively.

CONCLUSION: This model suggests that simvastatin provides a cost-effective approach to the long-term prevention of secondary CAD in Canada.

上一页 [1] [2] [3]

版面编辑：国际循环